Key result
In vitro infection with HHV-6A resulted in differential viral gene expression between CD4+ T lymphocytes and primary human astrocytes at 5 days post-infection.
HHV-6A exhibits differential gene expression in primary human astrocytes compared to CD4+ T lymphocytes, suggesting an alternative replication strategy to evade immune detection in neural glial cells.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for HHV-6A glial tropism; leaves open any clinical relevance to neuroinflammation.
Human herpesvirus 6 (HHV-6) is a ubiquitous virus that has been associated with a wide spectrum of diseases, such as exanthem infantum, multiple sclerosis, seizures, encephalitis/meningitis, and more recently, mesial temporal lobe sclerosis. Although HHV-6 is known to predominately infect CD4+ T lymphocytes, its ability to infect neural glial cells has been demonstrated both in vitro and in vivo. Reactivation of latent HHV-6 infection in the brain has recently been suggested to play a role in the development of neuropathogenesis. To investigate the association of viral gene expression and disease pathogenesis, we developed a multi-virus array containing all open reading frames of the HHV-6 virus and other pathogenically related viruses (EBV, HBV, HHV-8, HIV-1, HTLV-1, HTLV-2) to study expression of viral gene transcripts. In this study, we infected CD4+ T lymphocytes and primary human astrocytes derived from brain biopsy material in vitro with the more neurotropic HHV-6A strain. Hierarchal cluster analysis based on gene expression over time suggested a temporally regulated herpesvirus transcription process. Furthermore, we compared viral gene expression in CD4+ T lymphocytes and primary human astrocytes at peak viral load levels (>10(8) copies of virus/10(6) cells) at 5 days post-infection. Differential expression of HHV-6A genes was observed between CD4+ T lymphocytes and primary human astrocytes. Absence of a number of HHV-6 genes detected at 5 days post-infection in primary human astrocytes suggests an alternative replication strategy used by HHV-6 to evade immune detection and allow establishment of persistent infection in neural glial cells.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2006) studied HHV-6A infection. HHV-6A infection vs. CD4+ T lymphocytes vs primary human astrocytes was evaluated on Viral gene expression at peak viral load levels. In vitro infection with HHV-6A resulted in differential viral gene expression between CD4+ T lymphocytes and primary human astrocytes at 5 days post-infection.
Synapse has enriched 10 related papers. Consider them for comparative context: